Boronic acid, specifically B-[4-[(cyclopropylamino)sulfonyl]phenyl]- (CAS 871329-67-8), is an organic compound characterized by the presence of a boronic acid functional group, which features a boron atom bonded to a hydroxyl group and an aryl group. This compound contains a phenyl ring substituted with a sulfonamide group, which is linked to a cyclopropylamino moiety. The presence of the boronic acid group allows for potential applications in medicinal chemistry, particularly in drug design and synthesis, as it can participate in reversible covalent bonding with diols and other nucleophiles. The sulfonamide group contributes to the compound's solubility and reactivity, making it useful in various chemical reactions, including cross-coupling reactions. Additionally, the cyclopropyl group can influence the compound's biological activity and pharmacokinetics. Overall, this compound exemplifies the versatility of boronic acids in organic synthesis and their significance in developing therapeutic agents.

Boronic acid,B-[4-[(cyclopropylamino)sulfonyl]phenyl]-

871329-67-8: Boronic acid, specifically B-[4-[(cyclopropylamino)sulfonyl]phenyl]- (CAS 871329-67-8), is an organic compound characterized by the presence of a boronic acid functional group, which features a boron atom bonded to a hydroxyl group and an aryl group. This compound contains a phenyl ring substituted with a sulfonamide group, which is linked to a cyclopropylamino moiety. The presence of the boronic acid group allows for potential applications in medicinal chemistry, particularly in drug design and synthesis, as it can participate in reversible covalent bonding with diols and other nucleophiles. The sulfonamide group contributes to the compound's solubility and reactivity, making it useful in various chemical reactions, including cross-coupling reactions. Additionally, the cyclopropyl group can influence the compound's biological activity and pharmacokinetics. Overall, this compound exemplifies the versatility of boronic acids in organic synthesis and their significance in developing therapeutic agents.

CAS 871329-67-8

Boronic acid,B-[4-[(cyclopropylamino)sulfonyl]phenyl]-

N-Cyclopropyl 4-boronobenzenesulfonamide

Ref: IN-DA004OTB

4-(N-Cyclopropylsulphamoyl)benzeneboronic acid

Ref: 54-OR4214

(4-(N-Cyclopropylsulfamoyl)phenyl)boronic acid

Ref: 10-F232223